Skip to main content
OpenTrials

Clinical trial condition

Exocrine Pancreatic Insufficiency

Explore clinical trials studying Exocrine Pancreatic Insufficiency. Study availability and eligibility vary by location and protocol.

104 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Exocrine Pancreatic Insufficiency trial results

Completed

OPTION 2: A Trial to Assess the Safety and Efficacy of MS1819 in Enteric Capsules in Patients With Cystic Fibrosis

NCT04375878

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Cystic Fibrosis (CF), +8 more
Locations
  • Investigator Site 105 Long Beach, California, United States
  • Investigator Site 102 Altamonte Springs, Florida, United States
  • Investigator Site 107 Miami, Florida, United States
  • Investigator Site 101 Glenview, Illinois, United States
View all 15 locations
View Trial Details
Completed

Special Investigation of LipaCreon on Long-term Use in Patients With Pancreatic Exocrine Insufficiency

NCT01427725

Conditions
Digestive System Diseases, Exocrine Pancreatic Insufficiency, Pancreatic Diseases
Locations
  • Research facility ID ORG-000247 Aichi, Japan
  • Research facility ID ORG-000216 Aichi, Japan
  • Research facility ID ORG-000214 Aichi, Japan
  • Research facility ID ORG-000215 Aichi, Japan
View all 189 locations
View Trial Details
Completed

Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

NCT01427712

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +6 more
Locations
  • Site Reference ID/Investigator# 73813 Aichi, Japan
  • Site reference ID/Investigator # 96698 Aichi, Japan
  • Research facility ID ORG-000141 Aichi, Japan
  • Site reference ID/Investigator no. ORG-000842 Aichi, Japan
View all 21 locations
View Trial Details
Completed

OPTION: A Trial to Assess the Safety & Efficacy of MS1819 in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis

NCT03746483

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Cystic Fibrosis (CF), +8 more
Locations
  • Investigator Site 105 Long Beach, California, United States
  • Investigator Site 102 Altamonte Springs, Florida, United States
  • Investigator Site 107 Miami, Florida, United States
  • Investigator Site 101 Glenview, Illinois, United States
View all 14 locations
View Trial Details
Completed

Phase 2 Combination Study With Escalating Doses of MS1819-SD on Top of a Stable Dose of PPEs

NCT04302662

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Cystic Fibrosis Gastrointestinal Disease, +8 more
Locations
  • Országos Korányi TBC és Pulmonológiai Intézet Cisztás Fibrózis Részleg Budapest, Hungary
  • Borsod-Abaúj-Zemplén Megyei Központi Kórház és Egyetemi Oktatókórház, Gyermekegészségügyi Központ Miskolc, Hungary
  • Somogy Megyei Kaposi Mór Oktató Kórház, Mosdósi telephelye Mosdósi Gyermekrehabilitációs és Gyermekpulmonológiai Egység Mosdós, Hungary
  • Tüdőgyógyintézet Törökbálint Gyermekpulmonológiai Osztály és Szakrendelés Törökbálint, Hungary
View Trial Details

Related conditions